bilaterals.org logo
bilaterals.org logo

RCEP & intellectual property

An analysis of the leaked IP chapter proposed for the RCEP shows that Japan and South Korea are proposing intellectual property (IP) provisions referred to as TRIPS-plus, which go far beyond the obligations under the World Trade Organisation’s Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS).

The proposed provisions seek to extend pharmaceutical corporations’ patent terms beyond the usual 20 years and also would require data exclusivity that limits competition. Such provisions are a cause for great concern among public health groups over their potential adverse impact on access to affordable medicines.

RCEP also treats IP as an investment made by investor corporations, allowing private investment disputes (ISDS) to be raised against the host country whenever there is a threat to their IP. Treating IP as an investment, and subjecting it to treaty arbitration, can have undesirable impacts on the hard-bargained flexibilities in IP laws and on public health safeguards that countries like India have earned over the years.

Further, civil society groups have expressed concern about the copyright protection standards proposed under the RCEP IP Chapter which could stifle creativity and free speech.

The leaked IP chapter also pushes for accession by all RCEP member states to the 1991 Act of the International Convention for the Protection of New Varieties of Plants (UPOV 1991), to which only seven of the RCEP negotiating countries are already member. UPOV 1991 provides monopoly rights to plant breeder rights at the cost of farmers’ rights, making it illegal for farmers to save seeds of protected vartieties.

Data exclusivity provisions in the IP chapter may extend the patent protection periods of agrochemical products as well, putting upward pressure on food prices.

RCEP governments must recall their international, regional and national commitments to respect, protect and fulfill the right to health including the right to access affordable medicines. In their quest for greater economic integration, RCEP negotiating countries must not put the lives and health of millions of people in the Asia-Pacific region at risk.


DNP+ response to RCEP negotiations on Intellectual Property ongoing in Thailand
Japan is pushing for intellectual property rules in the Regional Comprehensive Economic Partnership that will undermine and delay access to affordable generic medecine in Asia.
Don’t trade our lives away in free trade negotiations
To sign the RCEP and start negotiations on a FTA with the US when the Indian economy is on the brink of economic downturn and needs strong domestic policies is a decision that is not in national or public interest.
Dozens of grassroots groups want changes to ‘secret’ trade pact
While some states in East and Southeast Asia favor the 16-nation RCEP trade deal, many civil society groups say it lacks transparency and public participation.
Employment crisis and free trade agreements( FTAs) : Why workers should reject RCEP
Trade unions, farmers groups, health activists, and other people’s movements are planning to organise a series of events to put pressure on the Government of India to withdraw from RCEP negotiations.
Free people from ‘dictatorship’ of 0.01%
Through RCEP, Asian countries may be dragged into the TPP under pressure of harmonisation, especially on issues related to seed, warns Vandana Shiva
India protects drug, agriculture business at RCEP
Three harmful provisions concerning pharmaceuticals and agriculture which were part of the RCEP have been withdrawn.
India to oppose anti-generics proposals at RCEP meet
India firm in opposing proposals that could hinder global access to affordable generic drugs
India will not cross red lines on generic drugs in RCEP, but stay vigilant, say officials
Healthcare watchers are calling on India to resist RCEP
India’s withdrawal from RCEP a breather on many fronts
India’s decision to pull out of RCEP means its policy on access to inexpensive drugs will not be under pressure.
Indonesia and RCEP: Beware the public health risks
Proposals from Japan and South Korea would require patent law changes in several RCEP countries, including Indonesia.
Interview with Loon Gangte
Loon Gangte is an Indian activist living with HIV and hepatitis C, founder of the Delhi Network of Positive People.
Investment protection proposals under RCEP threaten India’s pharma industry
Free trade agreements like the RCEP will infringe on India’s intellectual property laws. India must stand its ground in the interest of public health.
Is India holding the line against another TPP?
Of the RCEP negotiating countries, it is India, rather than China, that has been the most outspoken in opposing US-style trade rules.
Is Indonesia’s IPR Framework incompatible with RCEP?
On intellectual property rights, there’s a serious gap between domestic Indonesian law and the structures of the proposed RCEP
Keep agriculture and dairy out of RCEP negotiations, farmers’ body tells government
The RCEP will destroy farm livelihoods especially in the domestic dairy sector.
Law professors address RCEP negotiators on copyright
The recent death of the TPP has thrust RCEP further into the spotlight, and raised the stakes both for its sixteen prospective parties, and for lobbyists with designs to stamp their own mark on the text’s intellectual property and e-commerce chapters.
Malaysian civil society & farmer groups’ memorandum on RCEP & plant variety protection
RCEP negotiations must not include obligation to join or implement UPOV systems and in anyway undermine farmers’ rights
Médecins Sans Frontières warns about IP inclusion in Asian FTA
The inclusion of intellectual property in the ongoing negotiations of the Regional Comprehensive Economic Partnership between 16 countries, most of them Asian, is raising concerns about “TRIPS-plus” measures that could jeopardise generic drugs production in India, according to Médecins Sans Frontières.
Medicines in India likely to be costlier due to RCEP trade pact
However, the key issues holding the final text of these negotiations don’t seem to be getting resolved.
Meet RCEP, a trade agreement in Asia that’s even worse than TPP or ACTA
It’s been a big few weeks for leaked trade agreements. Just when we thought we had seen all the leaked text of the Trade in Services Agreement (TISA), Wikileaks went ahead and published some more yesterday. And on the same day, a leaked draft of the intellectual property chapter of yet another trade agreement, the Regional Comprehensive Economic Partnership (RCEP) was leaked by Knowledge Ecology International (KEI).